Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on April 23, 2025

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences Announces the Release of its Sustainability Report

MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today …

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start in 2026 and aiming for approval in …

Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn

Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn

Eerste Amerikaanse patiënt gedoseerd in ATALANTA-1 studie met GLPG5101 Mantelcellymfoom (MCL), een hematologische maligniteit met een hoge onvervulde behoefte, geselecteerd als hoofdindicatie voor het GLPG5101-programma; pivotale ontwikkeling gepland voor …

Verses AI Inc. Announces Proposed Public Offering of Securities

Verses AI Inc. Announces Proposed Public Offering of Securities

VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE: VERS)(OTCQB: VRSSD) (“Verses” or the “Company”) is pleased to announce an offering (the “Offering”) of securities in Canada under the base shelf prospectus of the Company …

Oxford Instruments NanoScience installs two of its largest modular Dilution Refrigerators

Oxford Instruments NanoScience installs two of its largest modular Dilution Refrigerators

Oxford Instruments NanoScience announces that it has installed the first two of a number of its largest modular dilution refrigerators, the ProteoxQX. OXFORD, UNITED KINGDOM, April 23, 2025 /⁨EINPresswire.com⁩/ -- Oxford Instruments NanoScience is …

GWM Unveils its Global Strategy at Auto Shanghai 2025: From China’s GWM to a Global Brand

GWM Unveils its Global Strategy at Auto Shanghai 2025: From China’s GWM to a Global Brand

Baoding, China , April 23, 2025 (GLOBE NEWSWIRE) -- On April 23, 2025, the 21st Shanghai International Automobile Industry Exhibition officially opened. GWM unveiled its exhibition at Hall 7.1, covering over 6,500 square meters, presenting two core product …

Mounfit Under Review: Natural Mounjaro Ingredients Recipe to Lose Weight Safely

Mounfit Under Review: Natural Mounjaro Ingredients Recipe to Lose Weight Safely

Aurora, Colorado, April 23, 2025 (GLOBE NEWSWIRE) -- Introduction Understanding the Modern Weight Loss Struggle In 2025, millions continue to struggle with stubborn weight gain, not because they lack willpower, but because the rules of metabolism have …

Best SARMS for Cutting and Bulking to Buy 2025 - Best SARMS for Sale for Muscle Growth, Fat Loss and Bodybuilding- By CrazyBulk

Best SARMS for Cutting and Bulking to Buy 2025 - Best SARMS for Sale for Muscle Growth, Fat Loss and Bodybuilding- By CrazyBulk

Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- If you’re looking to transform your physique with lean muscle growth, SARMs (Selective Androgen Receptor Modulators) are incredibly popular. Bodybuilders are buying SARMs for bulking and cutting and …

Sarms Vs Steroids – The Best Sarms And Legal Steroids For Cutting, Bulking And Bodybuilding In 2025 Tested And Rated – By Crazy Bulk.

Sarms Vs Steroids – The Best Sarms And Legal Steroids For Cutting, Bulking And Bodybuilding In 2025 Tested And Rated – By Crazy Bulk.

New York City, April 23, 2025 (GLOBE NEWSWIRE) -- SARMs are a rather new proposition on the market compared to steroids.  An enthusiast of the fitness culture would admit to having heard about SARMs or steroids at some point.  They enjoy a better …

United Nations Alliance of Civilizations Meeting in Geneva Concludes with Key Recommendations on AI Governance and Launches HUMAN-AI-T: A Global Initiative to Integrate Humanity into Artificial Intelligence

United Nations Alliance of Civilizations Meeting in Geneva Concludes with Key Recommendations on AI Governance and Launches HUMAN-AI-T: A Global Initiative to Integrate Humanity into Artificial Intelligence

United Nations Alliance of Civilizations Meeting in Geneva Concludes with Key Recommendations on AI Governance and Launches HUMAN-AI-T: A Global Initiative to Integrate Humanity into Artificial Intelligence UNAOC AI for #OneHumanity: Human-Centered …

La Reunión de la Alianza de Civilizaciones de las Naciones Unidas en Ginebra concluye con recomendaciones clave sobre la gobernanza de la IA y lanza HUMAN-AI-T: una iniciativa global para integrar la humanidad en la inteligencia artificial

La Reunión de la Alianza de Civilizaciones de las Naciones Unidas en Ginebra concluye con recomendaciones clave sobre la gobernanza de la IA y lanza HUMAN-AI-T: una iniciativa global para integrar la humanidad en la inteligencia artificial

La Reunión de la Alianza de Civilizaciones de las Naciones Unidas en Ginebra concluye con recomendaciones clave sobre la gobernanza de la IA y lanza HUMAN-AI-T: una iniciativa global para integrar la humanidad en la inteligencia artificial UNAOC AI for # …

Colon Broom Reviews: Weight loss,Ingredients - Does Colon Broom Work (UK,Canada/USA)- Consumer Reports & Side Effect

Colon Broom Reviews: Weight loss,Ingredients - Does Colon Broom Work (UK,Canada/USA)- Consumer Reports & Side Effect

San Francisco, California, April 23, 2025 (GLOBE NEWSWIRE) -- In a world where every other product tries to be a fiber supplement or detox product, ColonBroom is a great, high-strength formula that does its best to maximize digestive health, heal …

Industry Sciences One launches IS1 Consulting: Strategic advisory services for the life sciences sector

Industry Sciences One launches IS1 Consulting: Strategic advisory services for the life sciences sector

CRANBURY, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- Industry Sciences One (IS1), a division of MJH Life Sciences®, today announced the launch of IS1 Consulting, a custom consulting network designed to support decision-makers across the life sciences with …

Mitolyn Reviews (Investigative Warning): 2025 Shocking Consumer Reports on Ingredients, Side Effects And Complaints.

Mitolyn Reviews (Investigative Warning): 2025 Shocking Consumer Reports on Ingredients, Side Effects And Complaints.

Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- In terms of weight loss supplements, actual consumer experiences and real-life outcomes are more significant than promotional exaggeration.  As Mitolyn quickly captures interest, individuals are posing …

Cartier Resources Closes Offering with Paradigm Capital and Concurrent Offering for Aggregate Gross Proceeds of $11,398,596

Cartier Resources Closes Offering with Paradigm Capital and Concurrent Offering for Aggregate Gross Proceeds of $11,398,596

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VAL-D’OR, Québec, April 23, 2025 (GLOBE NEWSWIRE) -- Cartier Resources Inc. (TSX-V: ECR) (“Cartier” or the “Corporation”) is pleased to announce that …

Ressources Cartier procède à la clôture d’un placement avec Paradigm Capital et d’un placement concommittant pour un produit brut total de 11 398 596 $.

Ressources Cartier procède à la clôture d’un placement avec Paradigm Capital et d’un placement concommittant pour un produit brut total de 11 398 596 $.

LE PRÉSENT COMMUNIQUÉ DE PRESSE N’EST PAS DESTINÉ À ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES POUR DIFFUSION AUX ÉTATS-UNIS. VAL-D’OR, Québec, 23 avr. 2025 (GLOBE NEWSWIRE) -- Ressources Cartier Inc. (TSX-V : ECR) (« Cartier » ou la « Société ») est …

CentralReach Named a Top AI Company of 2025 by the Software Report

CentralReach Named a Top AI Company of 2025 by the Software Report

Fort Lauderdale, FL, April 23, 2025 (GLOBE NEWSWIRE) -- CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced it has been named to the Software Report’s 2025 Top AI Companies …

Ashwagandha Testosterone Boost: Does Ashwagandha Increase Testosterone? Testosil Supplement Review

Ashwagandha Testosterone Boost: Does Ashwagandha Increase Testosterone? Testosil Supplement Review

Las Vegas, April 23, 2025 (GLOBE NEWSWIRE) -- Ashwagandha, pronounced as ash-wa-gan-da, is a small evergreen plant that has gained popularity among health enthusiasts as a supplement. It is classified as an 'adaptogen', which means that it is a natural …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service